---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-026414"
form_type: "8-K"
ticker: "SCNX"
cik: "0001382574"
company_name: "Scienture Holdings, Inc."
filed_at: "2026-05-29T21:00:24+00:00"
generated_at: "2026-05-29T21:02:52.947674+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Scienture CFO Eric Sherb resigns; co-CEO Narasimhan Mani named interim CFO

## Summary
- Eric Sherb resigned as CFO effective May 26, 2026; cited personal reasons, no disagreement with management or board.
- Dr. Narasimhan Mani appointed Interim CFO same day; Mani also serves as co-CEO, President, and director.
- Mani holds an MBA in Finance from Columbia Business School and has 25+ years in pharma leadership roles.
- No material transaction or family relationship between Mani and the company; employment governed by existing agreement.
- Mani previously served as CEO of Kesin Pharma and Xiromed, and VP strategy at Amneal Pharmaceuticals.

## SEC filing metadata
- accession: 0001493152-26-026414
- form_type: 8-K
- ticker: SCNX
- cik: 0001382574
- company_name: Scienture Holdings, Inc.
- filed_at: 2026-05-29T21:00:24+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1382574/000149315226026414/0001493152-26-026414-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1382574/000149315226026414/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-026414
- JSON: https://secwatch.observer/filing/0001493152-26-026414.json
- Plain text: https://secwatch.observer/filing/0001493152-26-026414.txt

## Source-grounded claims
- claim_id: 1c63ff2432
  claim: Narasimhan Mani was appointed as Interim Chief Financial Officer at Scienture Holdings, Inc..
  evidence_excerpt: the Company appointed Dr. Narasimhan Mani (age 51) to serve as the Company’s Interim Chief Financial Officer ("Interim CFO") effective as of May 26, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1382574/000149315226026414/0001493152-26-026414-index.htm
- claim_id: 462181d1e3
  claim: Eric Sherb resigned as Chief Financial Officer at Scienture Holdings, Inc..
  evidence_excerpt: On May 26, 2026, Eric Sherb, the Chief Financial Officer ("CFO") of Scienture Holdings, Inc. (the "Company"), formally resigned his position as CFO and advised the Company that his resignation was due to personal reasons and not a result of any dispute or disagreement with the Company, its management, or its board of directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1382574/000149315226026414/0001493152-26-026414-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.